Advertisement

Nonantimuscarinic treatment for overactive bladder: a systematic review

Published:February 03, 2016DOI:https://doi.org/10.1016/j.ajog.2016.01.156
      The purpose of the study was to determine the efficacy and safety of nonantimuscarinic treatments for overactive bladder. Medline, Cochrane, and other databases (inception to April 2, 2014) were used. We included any study design in which there were 2 arms and an n > 100, if at least 1 of the arms was a nonantimuscarinic therapy or any comparative trial, regardless of number, if at least 2 arms were nonantimuscarinic therapies for overactive bladder. Eleven reviewers double-screened citations and extracted eligible studies for study: population, intervention, outcome, effects on outcome categories, and quality. The body of evidence for categories of interventions were summarized and assessed for strength. Ninety-nine comparative studies met inclusion criteria. Interventions effective to improve subjective overactive bladder symptoms include exercise with heat and steam generating sheets (1 study), diaphragmatic (1 study), deep abdominal (1 study), and pelvic floor muscle training exercises (2 studies). Pelvic floor exercises are more effective in subjective and objective outcomes with biofeedback or verbal feedback. Weight loss with diet and exercise, caffeine reduction, 25-50% reduction in fluid intake, and pelvic floor muscle exercises with verbal instruction and or biofeedback were all efficacious. Botulinum toxin A improves urge incontinence episodes, urgency, frequency, quality of life, nocturia, and urodynamic testing parameters. Acupuncture improves quality of life and urodynamic testing parameters. Extracorporeal magnetic stimulation improves urodynamic parameters. Mirabegron improves daily incontinence episodes, nocturia, number of daily voids, and urine volume per void, whereas solabegron improves daily incontinence episodes. Short-term posterior tibial nerve stimulation is more efficacious than pelvic floor muscle training exercises and behavioral therapy for improving: urgency, urinary incontinence episodes, daily voids, volume per void, and overall quality of life. Sacral neuromodulation is more efficacious than antimuscarinic treatment for subjective improvement of overactive bladder and quality of life. Transvaginal electrical stimulation demonstrates subjective improvement in overactive bladder symptoms and urodynamic parameters. Multiple therapies, including physical therapy, behavioral therapy, botulinum toxin A, acupuncture, magnetic stimulation, mirabegron, posterior tibial nerve stimulation, sacral neuromodulation, and transvaginal electrical stimulation, are efficacious in the treatment of overactive bladder.

      Key words

      To read this article in full you will need to make a payment

      References

        • Stewart W.F.
        • Van Rooyen J.B.
        • Cundiff G.W.
        • et al.
        Prevalence and burden of overactive bladder in the United States.
        World J Urol. 2003; 20: 327-336
        • Ju R.
        • Garrett J.
        • Wu J.M.
        Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States.
        Int Urogynecol J. 2014; 25: 479-484
      1. Hartmann KE, McPheeters ML, Biller DH, et al. Prepared by the Vanderbilt Evidence-based Practice Center under Contract No 290-2007-10065-I. Evid Rep Technol Assess (Summ) Rockville, MD: Agency for Healthcare Research and Quality; 2009. Treatment of Overactive Bladder in Women; pp. 1–8. AHRQ Publication No. 09-E017.

        • Reynolds W.S.
        • McPheeters M.
        • Blume J.
        • Surawicz T.
        • Worley K.
        • Wang L.
        • et al.
        Comparative effectiveness of anticholinergic therapy for overactive bladder in women: a systematic review and meta-analysis.
        Obstet Gynecol. 2015; 125: 1423-1432
        • Gormley E.A.
        • Lightner D.J.
        • Burgio K.L.
        • Chai T.C.
        • Clemens J.Q.
        • Culkin D.J.
        • et al.
        Diagnosis and treatment of overactive bladder (nonneurogenic) in adults: AUA/SUFU guideline.
        J Urol. 2012; 188: 2455-2463
        • Lucas M.G.
        • Bedretdinova D.
        • Bosch J.L.H.R.
        • Burkhard F.
        • Cruz F.
        • Nambiar A.K.
        • et al.
        EAU guidelines on urinary incontinence.
        Eur Assoc Urol. 2014; : 7-126
        • Peters K.M.
        • Macdiarmid S.A.
        • Wooldridge L.S.
        • Leong F.C.
        • Shobeiri S.A.
        • Rovner E.S.
        • et al.
        Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
        J Urol. 2009; 182: 1055-1061
        • Siegel S.
        • Noblett K.
        • Mangel J.
        • Griebling T.L.
        • Sutherland S.E.
        • Bird E.T.
        • et al.
        Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder.
        Neurourol Urodyn. 2015; 34: 224-230
        • Visco A.G.
        • Brubaker L.
        • Richter H.E.
        • Nygaard I.
        • Paraiso M.F.
        • Menefee S.A.
        • et al.
        Pelvic Floor Disorders Network: Anticholinergic therapy vs. onabotulinumtoxin a for urgency urinary incontinence.
        N Engl J Med. 2012; 367: 1803-1813
        • Hay-Smith E.J.
        • Bø Berghmans L.C.
        • Hendriks H.J.
        • de Bie R.A.
        • van Waalwijk van Doorn E.S.
        Pelvic floor muscle training for urinary incontinence in women.
        Cochrane Database Syst Rev. 2001; 1: CD001407
        • Wallace B.C.
        • Small K.
        • Brodley C.E.
        • Lau J.
        • Trikalinos T.A.
        Deploying an interactive machine learning system in an evidence-based practice center: Abstrackr. In: Proceedings of the 2nd ACM SIGHIT International Health Informatics Symposium (IHI).
        ACM. 2012; : 819-824
      2. Cochrane Collaboration Handbook. Section 8.5: The Cochrane Collboration’s tool for assessing risk of bias. Accessed Jul 24, 2015; chapter 8/table 85.

        • Owens D.K.
        • Lohr K.N.
        • Atkins D.
        • Treadwell J.R.
        • Reston J.T.
        • Bass E.B.
        • et al.
        AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions: Agency for Healthcare Research and Quality and the effective health-care program.
        J Clin Epidemiol. 2010; 63: 513-523
        • Seto H.
        • Ikeda H.
        • Hisaoka H.
        • Kurosawa H.
        Effect of heat-and steam-generating sheet on daily activities of living in patients with osteoarthritis of the knee: randomized prospective study.
        J Orthop Sci. 2008; 13: 187-191
        • Kim H.
        • Yoshida H.
        • Suzuki T.
        Effects of exercise treatment with or without heat and steam generating sheet on urine loss in community-dwelling Japanese elderly women with urinary incontinence.
        Geriatr Gerontol Int. 2011; 11: 452-459
        • Kim H.
        • Yoshida H.
        • Suzuki T.
        The effects of multidimensional exercise treatment on community-dwelling Japanese women with stress, urge, and mixed urinary incontinence: a randomized control trial.
        Int J Nurs Studies. 2011; 48: 1165-1172
        • Dougherty M.C.
        • Dwyer J.W.
        • Pendergast J.F.
        • Boyington A.R.
        • Tomlinson B.U.
        • Coward R.T.
        • et al.
        A randomized trial of behavioral management for continence with older rural women.
        Res Nurs Health. 2002; 25: 3-13
        • Hung H.C.
        • Hsiao S.M.
        • Chih S.Y.
        • Lin H.H.
        • Tsauo J.Y.
        An alternative intervention for urinary incontinence: retraining diaphragmatic deep abdominal and pelvic floor muscle coordinated function.
        Man Ther. 2010; 15: 273-279
        • Arruda R.M.
        • Castro R.A.
        • Sousa G.C.
        • Sartori M.G.
        • Baracat E.C.
        • Girao M.J.
        Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women.
        Int Urogynecol J. 2008; 19: 1055-1061
        • Oldham J.
        • Herbert J.
        • McBride K.
        Evaluation of a new disposable ‘‘tampon like’’ electrostimulation technology (Pelviva) for the treatment of urinary incontinence in women: a 12-week single blind randomized controlled trial.
        Neurourol Urodyn. 2013; 32: 460-466
        • Wang A.C.
        • Wang Y.Y.
        • Chen M.C.
        Single-blind, randomized trial of pelvic floor muscle training, biofeedback-assisted pelvic floor muscle training, and electrical stimulation in the management of overactive bladder.
        Urology. 2004; 63: 61-66
        • Schmidt A.P.
        • Sanches P.R.
        • Silva Jr., D.P.
        • Ramos J.G.
        • Nohama P.
        A new pelvic muscle trainer for the treatment of urinary incontinence.
        Int J Gynecol Obstet. 2009; 105: 218-222
        • Burgio K.L.
        • Goode P.S.
        • Locher J.L.
        • Umlauf M.G.
        • Roth D.L.
        • Richter H.E.
        • et al.
        Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial.
        JAMA. 2002; 288: 2293-2299
        • Ceresoli A.
        • Zanetti G.
        • Seveso M.
        • Bustros J.
        • Montanari E.
        • Guarneri A.
        • et al.
        Perineal biofeedback versus pelvic floor training in the treatment of urinary incontinence.
        Arch Int Urol LXV. 1993; 5: 559-560
        • Gameiro M.O.
        • Moreira E.H.
        • Gameiro F.O.
        • Moreno J.C.
        • Padovani C.R.
        • Amaro J.L.
        Vaginal weight cone versus assisted pelvic floor muscle training in the treatment of female urinary incontinence: a prospective, single-blind, randomized trial.
        Int Urogynecol J. 2010; 21: 395-399
        • Fonda D.
        • Woodward M.
        • D'Astoli M.
        • Chin W.F.
        sustained improvement of subjective quality of life in older community-dwelling people after treatment of urinary incontinence.
        Age Aging. 1995; 24: 283-286
        • Subak L.L.
        • Quesenberry C.P.
        • Posner S.F.
        • Cattolica E.
        • Soghikian K.
        The effect of behavioral therapy on urinary incontinence: a randomized controlled trial.
        Am J Obstet Gynecol. 2002; 100: 72-78
        • Bryant C.M.
        • Dowell C.J.
        • Fairbrother G.
        Caffeine reduction education to improve urinary symptoms: continence management.
        Br J Nurs. 2002; 11: 560-565
        • Subak L.L.
        • Wing R.
        • West D.S.
        • Franklin F.
        • Vittinghoff E.
        • Creasman J.M.
        • et al.
        Weight loss to treat urinary incontinence in overweight and obese women.
        N Engl J Med. 2009; 360: 481-490
        • Hashim H.
        • Abrams P.
        How should patients with an overactive bladder manipulate their fluid intake?.
        BJU Int. 2008; 102: 62-66
        • Wiseman P.A.
        • Malone-Lee J.
        • Rai G.S.
        Terodiline with bladder retraining for treating detrusor instability in elderly people.
        Br Med J. 1991; 302: 994-996
        • Ramsay I.N.
        • Ali H.M.
        • Hunter M.
        • Stark D.
        • McKenzie S.
        • Donaldson K.
        • et al.
        Prospective, randomized controlled trial of inpatient versus outpatient continence programs in the treatment of urinary incontinence in the female.
        Int Urogynecol J. 1996; 7: 260-263
        • Schreiner L.
        • dos Santos T.G.
        • Knorst M.R.
        • da Silva Filho I.G.
        Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women.
        Int Urogynecol J. 2010; 21: 1065-1070
        • Subak L.L.
        • Whitcomb E.
        • Shen H.
        • Saxton J.
        • Vittinghoff E.
        • Brown J.S.
        Weight loss: a novel and effective treatment for urinary incontinence.
        J Urol. 2005; 174: 190-195
        • Sahai A.
        • Khan M.S.
        • Dasgupta P.
        Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
        J Urol. 2007; 177: 2231-2236
        • Brubaker L.
        • Richter H.E.
        • Visco A.
        • Mahajan S.
        • Nygaard I.
        • Braun T.M.
        • et al.
        Refractory idiopathic urge urinary incontinence and botulinum A injection.
        J Urol. 2008; 180: 217-222
        • Flynn M.K.
        • Amundsen C.L.
        • Perevich M.
        • Liu F.
        • Webster G.D.
        Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder.
        J Urol. 2009; 181: 2608-2615
        • Dmochowski R.
        • Chapple C.
        • Nitti V.W.
        • Chancellor M.
        • Everaert K.
        • Thompson C.
        • et al.
        Efficacy and safety of onabotulinumtoxin a for idiopathic overactive bladder: a double-blind, placebo controlled randomized, dose ranging trial.
        J Urol. 2010; 194: 2416-2422
        • Dowson C.
        • Sahai A.
        • Watkins J.
        • Dasgupta P.
        • Khan M.S.
        The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trial.
        Int J Clin Pract. 2011; 65: 698-704
        • Rovner E.
        • Kennelly M.
        • Schulte-Baukloh H.
        • Zhou J.
        • Haag-Molkenteller C.
        • Dasgupta P.
        Urodynamic results and clinical outcomes with intra detrusor injections of onabotulinumtoxin A in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder.
        Neurourol Urodyn. 2011; 30: 556-562
        • Tincello D.G.
        • Kenyon S.
        • Abrams K.R.
        • Mayne C.
        • Toozs-Hobson P.
        • Taylor D.
        • et al.
        Botulinum toxin A versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX Study).
        Eur Urol. 2012; 62: 507-512
        • Denys P.
        • Le Normand L.
        • Ghout I.
        • Costa P.
        • Chartier-Kastler E.
        • Grise P.
        • et al.
        Efficacy and safety of low doses of onabotulinumtoxin A for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study.
        Eur Urol. 2012; 61: 520-529
        • Nitti V.W.
        • Dmochowski R.
        • Herschorn S.
        • Sand P.
        • Thompson C.
        • Nardo C.
        • et al.
        Onabotulinumtoxin A for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.
        The J Urol. 2013; 189: 2186-2193
        • Chapple C.
        • Sievert K.D.
        • MacDiarmid S.
        • Khullar V.
        • Radziszewski P.
        • Nardo C.
        • et al.
        Onabotulinumtoxin A 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
        Eur Urol. 2013; 64: 249-256
        • Cohen B.L.
        • Barboglio P.
        • Rodriguez D.
        • Gousse A.E.
        Preliminary Results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units.
        Neurourol Urodyn. 2009; 28: 205-208
        • Brubaker L.
        • Gousse A.
        • Sand P.
        • Thompson C.
        • Patel V.
        • Zhou J.
        • et al.
        Treatment satisfaction and goal attainment with onabotulinumtoxin A in patients with incontinence due to idiopathic OAB.
        Int Urogynecol J. 2012; 23: 1017-1025
        • Emmons S.L.
        • Otto L.
        Acupuncture for overactive bladder: a randomized control trial.
        Am J Obstet Gynecol. 2005; 106: 138-142
        • Engberg S.
        • Cohen S.
        • Sereika S.M.
        The efficacy of acupuncture in treating urge and mixed incontinence in women: a pilot study.
        J Wound Ostomy Continence Nurs. 2009; 36: 661-670
        • Betschart C.
        • von Mandach U.
        • Seifert B.
        • Scheiner D.
        • Perucchini D.
        • Fink D.
        • et al.
        Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women.
        Phytomedicine. 2013; 20: 351-358
        • But I.
        Conservative treatment of female urinary incontinence with functional magnetic stimulation.
        Adult Urol. 2003; 61: 558-561
        • Suzuki T.
        • Yasuda K.
        • Yamanishi T.
        • Kitahara S.
        • Nakai H.
        • Suda S.
        • et al.
        Randomized, double-blind, sham-controlled evaluation of the effect of functional continuous magnetic stimulation in patients with urgency incontinence.
        Neurourol Urodyn. 2007; 26: 767-772
        • Morris A.R.
        • O'Sullivan R.
        • Dunkley P.
        • Moore K.H.
        Extracorporeal magnetic stimulation is of limited clinical benefit to women with idiopathic detrusor overactivity: a randomized sham controlled trial.
        Eur Urol. 2007; 52: 876-883
        • Bolukbas N.
        • Vural M.
        • Karan A.
        • Yalcin O.
        • Eskiyurt N.
        Effectiveness of functional magnetic versus electrical stimulation in women with urinary incontinence.
        Eur Med Phys. 2005; 41: 297-301
        • Herschorn S.
        • Barkin J.
        • Castro-Diaz D.
        • Frankel J.M.
        • Espuna-Pons M.
        • Gousse A.E.
        • et al.
        A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of theb3adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.
        J Urol. 2013; 82: 313-320
        • Khullar V.
        • Amarenco G.
        • Angulo J.C.
        • Cambronero J.
        • Hoye K.
        • Milsom I.
        • et al.
        Efficacy and tolerability of mirabegron, a b3-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European–Australian Phase 3 Trial.
        Eur Urol. 2013; 63: 283-295
        • Ohlstein E.H.
        • von Keitz A.
        • Michel M.C.
        A multicenter, double-blind, randomized, placebo-controlled trial of the b3-adrenoceptor agonist solabegron for overactive bladder.
        Eur Urol. 2012; 62: 834-840
        • Chapple C.R.
        • Kaplan S.A.
        • Mitcheson D.
        • Klecka J.
        • Cummings J.
        • Drogendijk T.
        • et al.
        Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a b 3-adrenoceptor agonist, in overactive bladder.
        Eur Urol. 2013; 64: 296-305
        • Peters K.M.
        • Carrico D.J.
        • Perez-Marrero R.A.
        • Khan A.U.
        • Wooldridge L.S.
        • Davis G.L.
        • et al.
        Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT Trial.
        J Urol. 2010; 183: 1438-1443
        • Finazzi-Agro E.
        • Petta F.
        • Sciobica F.
        • Pasqualetti P.
        • Musco S.
        • Bove P.
        Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial.
        J Urol. 2010; 184: 201-206
        • Svihra J.
        • Kurea E.
        • Lubtak J.
        • Kliment J.
        Neuromodulative treatment of overactive bladder-noninvasive tibial nerve stimulation.
        Bratisl Lek Listy. 2002; 103: 480-483
        • Weil E.H.
        • Ruiz-Cerda J.L.
        • Eerdmans P.H.
        • Janknegt R.A.
        • Bemelmans B.L.
        • van Kerrebroeck P.E.
        Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial.
        Neurourol Eur Urol. 2000; 37: 161-171
        • Houssana M.M.
        • Siegel S.W.
        • Nyeholt A.A.
        • Elhilali M.M.
        • van Kerrebroeck P.E.
        • Das A.K.
        • et al.
        Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety.
        J Urology. 2000; 163: 1849-1854
        • Hasan S.T.
        • Robson W.A.
        • Pridie A.K.
        • Neal D.E.
        Transcutaneous electrical nerve stimulation and temporary s3 neuromodulation.
        J Urol. 1996; 155: 2005-2011
        • Schmidt R.A.
        • Jonas U.
        • Oleson K.A.
        • Janknegt R.A.
        • Hassouna M.M.
        • Siegel S.W.
        • et al.
        Sacral nerve stimulation for treatment of refractory urinary urge incontinence.
        J Urol. 1999; 162: 352-357
        • Brubaker L.
        • Benson J.T.
        • Bent A.
        • Clark A.
        • Shott S.
        Transvaginal electrical stimulation for female urinary incontinence.
        Am J Obstet Gynecol. 1997; 177: 536-540
        • Indrekvam S.
        • Hunskaar S.
        Side effects, feasibility, and adherence to treatment during home-managed electrical stimulation for urinary incontinence: a Norwegian National Cohort of 3,198 Women.
        Neurourol Urodyn. 2002; 21: 546-552
        • Barroso J.C.
        • Ramos J.G.
        • Martins-Costa S.
        • Sanches P.R.
        • Muller A.F.
        Transvaginal electrical stimulation in the treatment of urinary incontinence.
        J Urol. 2005; 174: 1007-1012
        • Amaro J.L.
        • Gameiro M.O.
        • Padovani C.R.
        Effect of intravaginal electrical stimulation on pelvic floor muscle strength.
        Int Urogynecol J. 2005; 16: 355-358
        • Hay-Smith J.
        • Herderschee R.
        • Dumoulin C.
        • Herbison P.
        Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women: an abridged Cochrane systematic review.
        Eur J Phys Rehabil Med. 2012; 48: 689-705
        • Herderschee R.
        • Hay-Smith E.C.
        • Herbison G.P.
        • Roovers J.P.
        • Heineman M.J.
        Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women: shortened version of a Cochrane systematic review.
        Neurourol Urodyn. 2013; 32: 325-329
        • Van Kerrebroeck P.E.
        • van Voskuilen A.C.
        • Heesakkers J.P.
        • Lycklama á Nijholt A.A.
        • Siegel S.
        • et al.
        Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study.
        J Urol. 2007; 178: 2029-2034
        • MacDiarmid S.A.
        • Peters K.M.
        • Shobeiri S.A.
        • Wooldridge L.S.
        • Rovner E.S.
        • Leong F.C.
        • et al.
        Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.
        J Urol. 2010; 183: 234-240
        • Burgio K.L.
        • Locher J.L.
        • Goode P.S.
        • Hardin J.M.
        • McDowell B.J.
        • Dombrowski M.
        • et al.
        Behavioral vs. drug treatment for urge urinary incontinence in older women: a randomized controlled trial.
        JAMA. 1998; 280: 1995-2000
        • Mak H.L.
        • Cheon W.C.
        • Wong T.
        • Liu Y.S.
        • Tong W.M.
        Randomized controlled trial of foot reflexology for patients with symptomatic idiopathic detrusor overactivity.
        Int Urogynecol J. 2007; 18: 653-658
        • Marencak J.
        • Cossons N.H.
        • Darekar A.
        • Mills I.W.
        Investigation of the clinical efficacy and safety of pregabalin alone or combined with tolterodine in female subjects with idiopathic overactive bladder.
        Neurourol Urodyn. 2011; 30: 75-82
        • Nitti V.W.
        • Khullar V.
        • van Kerrebroeck P.
        • Herschorn S.
        • Cambronero J.
        • Angulo J.C.
        • et al.
        Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.
        Int J Clin Pract. 2013; 67: 619-632
        • Manecksha R.P.
        • Cullen I.M.
        • Ahmad S.
        • McNeill G.
        • Flynn R.
        • McDermott T.E.
        • et al.
        Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of a bobotulinum toxin A for refractory idiopathic detrusor overactivity.
        Eur Urol. 2012; 61: 228-235
        • Alewijnse D.
        • Metsemakers J.F.
        • Mesters I.E.
        • van den Borne B.
        Effectiveness of pelvic floor muscle exercise therapy supplemented with a health education program to promote long-term adherence among women with urinary incontinence.
        Neurourol Urodyn. 2003; 22: 284-295
        • Berghmans B.
        • van Waalwijk van Doorn E.
        • Nieman F.
        • de Bie R.
        • van den Brandt P.
        • Van Kerrebroeck P.
        Efficacy of physical therapeutic modalities in women with proven bladder overactivity.
        Eur Urol. 2002; 41: 581-587
        • Spruijt J.
        • Vierhout M.
        • Verstraeten R.
        • Janssens J.
        • Burger C.
        Vaginal electrical stimulation of the pelvic floor: a randomized feasibility study in urinary incontinent elderly women.
        Acta Obstet Gynecol Scand. 2003; 82: 1043-1048
        • Sutherland S.E.
        • Lavers A.
        • Carlson A.
        • Holtz C.
        • Kesha J.
        • Siegel S.W.
        sacral nerve stimulation for voiding dysfunction: one institution’s 11-year experience.
        Neurourol Urodyn. 2007; 26: 19-28
        • Taylor M.C.
        • Bates C.P.
        A double-blind crossover trial of baclofen: a new treatment for the unstable bladder syndrome.
        Br J Urol. 1979; 51: 504-505
        • Van Voskuilen A.C.
        • Oerlemans D.J.
        • Weil E.H.
        • de Bie R.A.
        • van Kerrebroeck P.E.
        Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study.
        Eur Urol. 2006; 49: 366-372
        • Kuo H.C.
        Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxin a for idiopathic detrusor overactivity refractory to antimuscarinics.
        Neurourol Urodyn. 2011; 30: 1242-1248
        • Levin P.J.
        • Wu J.M.
        • Siddiqui N.Y.
        • Amundsen C.L.
        Does obesity impact the success of an interstim test phase for the treatment of refractory urge urinary incontinence in female patients?.
        Female Pelv Med Reconstruct Surg. 2012; 18: 243-246
        • Wang A.C.
        • Chih S.Y.
        • Chen M.C.
        Comparison of electric stimulation and oxybutynin choloride in management of overactive bladder with special reference to urinary urgency: a randomized placebo-controlled trial.
        Urology. 2006; 68: 999-1004
        • Wing R.R.
        • Creasman J.M.
        • West D.S.
        • Richter H.E.
        • Myers D.
        • Burgio K.L.
        • et al.
        Improving urinary incontinence in overweight and obese women through modest weight loss.
        Obstet Gynecol. 2010; 116: 284-292
        • Wing R.R.
        • West D.S.
        • Grady D.
        • Creasman J.M.
        • Richter H.E.
        • Myers D.
        • et al.
        Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months.
        J Urol. 2010; 184: 1005-1010
        • Dowson C.
        • Watkins J.
        • Khan M.S.
        • Dasgupta P.
        • Sahai A.
        Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates.
        Eur Urol. 2012; 61: 834-839
        • Sahai A.
        • Dowson C.
        • Khan M.S.
        • Dasgupta P.
        Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
        BJU Int. 2009; 103: 1509-1515
        • Pham K.
        • Guralnick M.L.
        • O'Connor R.C.
        Unilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunction.
        Neurourol Urodyn. 2008; 27: 779-781
        • Pinto A.M.
        • Subak L.L.
        • Nakagawa S.
        • Vittinghoff E.
        • Wing R.R.
        • Kusek J.W.
        • et al.
        The effect of weight loss on changes in health-related quality of life among overweight and obese women with urinary incontinence.
        Qual Life Res. 2012; 21: 1685-1694
        • Ravindra P.
        • Jackson B.L.
        • Parkinson R.J.
        Botulinum toxin type A for the treatment of non-neurogenic overactive bladder: does using onabotulinum toxin A (Botox) onabobotulinum toxin A (Dysport) make a difference?.
        BJU Int. 2013; 112: 94-99
        • Scheepens W.A.
        • de Bie R.A.
        • Weil E.H.
        • van Kerrebroeck P.E.
        Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction.
        J Urol. 2002; 168: 2046-2050
        • Schmid D.M.
        • Sauermann P.
        • Werner M.
        • Schuessler B.
        • Blick N.
        • Muentener M.
        • et al.
        Experience with 100 cases treated with botulinum-a toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
        J Urol. 2006; 176: 177-185
        • Bower W.F.
        • Moore K.H.
        • Adams R.D.
        • Shepherd R.
        A urodynamic study of surface neuromodulation versus sham in detrusor instability and sensory urgency.
        J Urol. 1998; 160: 2133-2136
        • Hann-Chorng K.
        Reduction of urgency severity is associated with long-term therapeutic effect after intravesical onabotulinumtoxin A injection for idiopathic detrusor overactivity.
        Neurourol Urodyn. 2011; 30: 1497-1502
        • Leong R.K.
        • Marcelissen T.A.
        • Nieman F.H.
        • De Bie R.A.
        • Van Kerrebroeck P.E.
        • De Wachter S.G.
        Satisfaction and patient experience with sacral neuromodulation: results of a single center sample survey.
        J Urol. 2011; 185: 588-592
        • Seabra Rios L.A.
        • Panhoca R.
        • Mattos Jr., D.
        • Srugi M.
        • Bruschini H.
        Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: a single dose, 4 weeks, double-blind, randomized, placebo controlled trial.
        Neurourol Urodyn. 2007; 26: 773-778
        • Rufford J.
        • Hextal A.
        • Cardozo L.
        • Khullar V.
        A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women.
        Int Urogynecol J Pelvic Floor. 2003; 14: 78-83
        • Siegal S.W.
        • Catanzaro F.
        • Dijkema H.E.
        • Mostafa M.E.
        • Fowler C.J.
        • Gajewski J.B.
        • et al.
        long term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency and retention.
        J Urol. 2000; 56: 87-91
        • Groenendijk P.M.
        • Lycklama A.
        • Nyeholt A.A.
        • Heesakkers J.P.
        • van Kerrebroeck P.E.
        • Hassouna M.M.
        • Gajewski J.B.
        • et al.
        Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence.
        BJU Int. 2007; 101: 325-329
        • Hui E.
        • Lee P.S.
        • Woo J.
        Management of urinary incontinence in older women using videoconferencing versus conventional management: a randomized controlled trial.
        J Telemed Telecare. 2006; 123: 343
        • Gungor Ugurlucan F.
        • Onal M.
        • Aslan E.
        • Ayyildiz Erkan H.
        • Kizilkaya Beji N.
        • Yalcin O.
        Comparison of the effects of electrical stimulation and posterior tibial nerve stimulation in the treatment of overactive bladder syndrome.
        Gynecol Obstet Invest. 2013; 75: 46-55
        • Firoozi F.
        • Gill B.
        • Ingber M.S.
        • Moore C.K.
        • Rackley R.R.
        • Goldman H.B.
        • et al.
        Increasing patient preparedness for sacral neuromodulation improves patient reported outcomes despite leaving objective measures of success unchanged.
        J Urol. 2013; 190: 594-597
        • Kumari S.
        • Jain V.
        • Mandal A.K.
        • Singh A.
        Behavioral therapy for urinary incontinence in India.
        Int J Gynecol Obstet. 2008; 103: 125-130
        • Lamb S.E.
        • Pepper J.
        • Lall R.
        • Jorstad-Stein E.C.
        • Clark M.D.
        • Hill L.
        • et al.
        Group treatments for sensitive health care problems: a randomised controlled trial of group versus individual physiotherapy sessions for female urinary incontinence.
        BMC Women's Health. 2009; 9: 26
        • Lucioni A.
        • Rapp D.E.
        • Gong E.M.
        • Fedunok P.
        • Bales G.T.
        Intravesical botulinum type A toxin injection inpatients with overactive bladder: trigone versus trigone-sparing injection.
        Can J Urol. 2006; 13: 3291-3295
        • O'Reilly B.A.
        • Fynes M.
        • Achtari C.
        • Hiscock R.
        • Thomas E.
        • Murray C.
        • et al.
        A prospective randomised double-blind controlled trial evaluating the effect of trans-sacral magnetic stimulation in women with overactive bladder.
        Int Urogynecol J. 2008; 19 (497-450)
        • Peters K.M.
        • Killinger K.A.
        • Boura J.A.
        Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation?.
        Neurourol Urodyn. 2011; 30: 1489-1492
        • Resnick N.M.
        • Perera S.
        • Tadic S.
        • Organist L.
        • Riley M.A.
        • Schaefer W.
        • Griffiths D.
        What predicts and what mediates the response of urge urinary incontinence to biofeedback?.
        Neurourol Urodyn. 2013; 32: 408-415
        • Sander P.
        • Mouritsen L.
        • Andersen J.T.
        • Fischer-Rasmussen W.
        Evaluation of a simple, non-surgical concept for management of urinary incontinence (minimal care) in an open-access, interdisciplinary incontinence clinic.
        Neurourol Urodyn. 2000; 19: 9-17
        • Wallis M.C.
        • Davies E.A.
        • Tahlib L.
        • Griffiths S.
        Pelvic static magnetic stimulation to control urinary incontinence in older women: a randomized controlled trial.
        Clin Med Res. 2012; 10: 7-14
        • Gordon D.
        • Groutz A.
        • Ascher-Landsberg J.
        • Lessing J.B.
        • David M.P.
        • Razz O.
        Double-blind, placebo-controlled study of magnesium hydroxide for treatment of sensory urgency and detrusor instability: preliminary results.
        Br J Obstet Gynaecol. 1998; 105: 667-669
        • Naglie G.
        • Radomski S.B.
        • Brymer C.
        • Mathiasen K.
        • O’Rourke K.
        • Tomlinson G.
        A randomized, double-blind, placebo controlled crossover trial of nimopidine in older persons with detrusor instability and urge incontinence.
        J Urol. 2002; 167: 586-590